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Abstract: 
Huge flights of Canada geese turn off local park visitors with their messy, smelly 
"business cards." The superabundant white-tailed deer we love to watch also can do a 
number on your car at night and host the ticks that carry Lyme Disease. Blackbirds and 
gulls and coyotes and other critters bring their own problems when their numbers get out 
of hand. 
Most such problems reach their highest profile in urban/suburban areas where traditional 
animal-control techniques such as hunting and trapping are frowned upon or illegal. More 
and more people are calling for wildlife managers to use "fertility control"–-but is that 
concept really feasible on populations of free-ranging wildlife? The definitive answers–in 
the form of the latest science–are contained in a new Technical Review titled Wildlife 
Fertility Control. The 29-page Review notes that in the past, fertility control has been far 
less successful than observers had hoped, but thanks to new findings about animal 
reproductive systems, the technology is advancing rapidly and is being tested on several 
species on a small scale. Hurdles include the need to develop and commercialize effective 
vaccines or baits, cost-effective delivery systems, and public-agency acceptance of the 
technique. 
The new publication states that "birth control" will undoubtedly play a role in the science 
of wildlife management in the future. Managers face two major challenges: integrating 
contraceptive tactics with more conventional ways of managing critter numbers, and 
giving the public accurate information about the feasibility of using fertility control vs. 
lethal methods to reduce populations of deer and other long-lived species.  
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EXECUTIVE SUMMARY 
A number of wildlife species have become overabundant 
either locally or regionally in North America, including 
white-tailed deer (Odocoileus virginimus), Canada geese 
(Branta canadensis), coyotes (Canis latrans), various 
blackbird (Icterinae and Sturnus vulgaris) and gull (Lam) 
species, and double crested cormorants (Phalacmcorar 
auritus). These and other overabundant species cause a 
myriad of conflicts with humans, ranging from minor 
nuisance problems to serious habitat and crop destruction, 
spread of disease, and collisions with vehicles and aircraft. 
Traditional population management techniques for 
overabundant wildlife such as hunting and trapping 
increasingly are restricted or infeasible in parks and 
suburban areas. Thus, wildlife managers and administrators 
are being urged by a growing segment of the public to apply 
wildlife fertility control to manage populations of 
overabundant free-ranging wildlife. 
Wildlife fertility control has been less successful than 
hoped in the past, partly due to failure to understand 
reproductive strategies of targeted species. With an 
increasing research focus on contraceptive development, 
and more knowledge of animal reproductive systems and 
behaviors, fertility control as a technology is rapidly 
advancing. Wildlife fertility control is currently being 
tested in several species on a small scale and will 
undoubtedly hold a place as a wildlife management 
technique in the future. Major hurdles still include 
development of cost-effective delivery systems for effective 
products, public and natural resource agency acceptance of 
fertility control as a wildlife management practice, and 
commercialization of vaccines or baits. There are currently 
no contraceptive products available for commercial use. 
Investigational New Animal Drug (INAD) files have been 
established for several fertility control products. This 
allows for interstate transport of the investigational drug for 
use in studies to support the drug's approval. For a New 
Animal Drug to be approved, a drug sponsor must provide 
evidence of safety and substantial evidence of effectiveness 
in the target species. Environmental, human food, user 
safety, chemistry, and manufacturing issues must also be 
adequately addressed. Because contraceptive products for 
wildlife use will be a minor market, and the cost of 
obtaining authorization for their use by the Fl)A will be 
high, drug manufacturers will be reluctant to develop 
products on their own. Tberefore, natural resource agencies 
may need to be involved in product development. Product 
development is a nontraditional role for wildlife 
management agencies, but one that will be required if 
contraceptive products are to be used in anything other than 
a research context. 
Wildlife agencies and biologists have been reluctant to 
acknowledge the potential applicability of fertility control for 
managing wildlife populations, in part because the 
techniques available have been publicized as a replacement 
for sport hunting. In reality, it is doubtful if the cost or 
efficiency of delivery for contraceptive techniques would 
allow their use on free-ranging game populations outside of 
urban areas where hunting is typically prohibited anyway. 
The current techniques often have proved uneconomical or 
infeasible for practical implementation even in small, 
localized populations of game species such as deer. 
Furthermore, the species for which contraceptives primarily 
have been tested (long-lived species such as deer and horses) 
are those least suited for population reduction through use of 
fertility control. From the perspective of population 
dynamics, infertility agents are best suited for management 
of short-lived, highly fecund wildlife populations such as 
rodents and small buds. 
Despite the high cost and sometimes questionable feasibility 
of present contraceptive programs, more and more 
communities are opting to fund reproductive control of 
wildlife populations such as deer. Wildlife management 
agencies are increasingly willing to view fertility control as 
an alternative to other management tools for nongame 
species and for game species in areas where hunting is 
already restlicted. Public forums discussing the advantages 
and disadvantages of various management techniques will be 
more important in the future. The challenges for wildlife 
managers will be (1) to integrate potentially valuable 
contraceptive technologies with more conventional methods 
of wildlife population management and (2) to provide the 
public with accurate information about the length of time 
required for fertility control to reduce populations of long- 
lived species such as deer relative to lethal control. 
INTRODUCTION 
W i d  animals are valuable natural resources and vital 
components of a healthy ecosystem. Wildlife provides 
economic, recreational and aesthetic benefits, and to many 
people, the knowledge that wildlife exists is a positive 
benefit in itself. The rich wildlife resources in the United 
States are an important part of our heritage. For the last 70 
or more years, wildlife conservation agencies have focused 
on conserving and even increasing populations of many 
species of wildlife in the United States. In many cases, such 
as for the white-tailed deer and the Canada goose, these 
conservation efforts have been extremely successful, to the 
point where these species are locally overabundant. 
Although wildlife abundance is desirable in most cases, 
some populations may reach undesirably high levels and 
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cause either ecological damage or human-wildlife conflicts. 
Lf these populations are allowed to increase unregulated, 
they may adversely affect the overall health of the 
population or of other species sharing the ecosystem or may 
result in an unacceptable degree of environmental 
degradation. These populations also may result in an 
unacceptable level of human-animal conflict. Conflicts can 
include damage to agricultural commodities through 
depredations of livestock, crops, or forest resources. 
Buildings and other structures and properties can be 
damaged by nesting, burrowing, feeding or other wildlife 
activities. Damage can be relatively minor or can be severe 
enough to affect the livelihood of producers or property 
owners. Overabundant wildlife also can cause human health 
and safety issues; wildlife aircraft smkes and deer-vehicle 
collisions have increased at alarming rates. There is 
increasing concern about the potential for wildlife disease 
transmission to humans and livestock (e.g., Lyme disease, 
tuberculosis, pseudorabies, West Nile virus, chronic wasting 
disease). Many of the problems associated with 
overabundant wildlife occur in areas recently converted by 
suburban development or in parks or preserves. In many of 
these areas, regulation of some wildlife populations through 
conventional means, such as hunting, translocation, culling, 
or habitat modification has not been effective or feasible, or 
is precluded because of human presence. 
The general public has a positive attitude toward wildlife 
that can only be sustained if managers are able to minimize 
the negative impacts of overabundant wildlife. Prevention of 
the many and varied types of wildlife damage that occur in 
the United States involves an integrated pest management 
approach by federal, state and private landowners. The need 
for wildlife management is increasing as people continue to 
encroach upon natural habitats and human-wildlife conflicts 
become more frequent. At the same time, the public is 
becoming intolerant of perceived inhumane means of 
control. A growing interest in nonlethal methods for 
population control of nuisance or damaging wildlife species 
has fostered research in wildlife contraception. Because 
fertility control acts by reducing birth rates, rather than by 
increasing mortality rates, it is perceived by the public as 
being more humane and morally acceptable than 
conventional population control methods. 
There are a number of complex technical, biological, 
economic and legal issues that will need to be addressed 
before infertility agents can be used widely in field 
situations. Some of these issues deal with the technology 
itself. If contraception is to become a successful wildlife 
management tool, the vaccines or infertility compounds will 
first need to be effective in inducing infertility. The most 
important fundamental for success in inducing infertility in a 
particular species is development of an understanding of the 
reproductive behavior and physiology of that species and the 
use of that knowledge to select the most suitable infertility 
agent. Examples of the reproductive behaviors that need to 
be considered are (1) is the species a seasonal or year-round 
breeder?, (2) is it monogamous or polygamous?, (3) is it 
monestrus or multiestrus?, and (4) does it need a specific 
vegetation, temperature, or landscape to be successful in 
reproduction? Each of these factors may impact the 
effectiveness of a particular infertility agent. Infertility 
agents also will have to be safe for the animals being treated, 
for nontarget animals, and for the human population and the 
environment. They will need to be cost effective relative to 
other methods of population management, meaning that they 
must be easily deliverable to large numbers of free-ranging 
animals in the target populations. Legally, they must be 
authorized through a regulatory agency such as the Food and 
Drug Administration (FDA), and they must be used 
according to the statutes and regulations set forth by federal 
and state agencies. In addition, they need to be socially 
acceptable for that particular use. 
The American Association of Wildlife Veterinarians 
(AAWV) stated in a 1993 resolution that fertility control 
may be an acceptable means of population regulation in 
free-ranging wild animals if the following conditions are 
met. 
1) The compound does not affect the health of target species 
and humans. 
2) A risk assessment is completed delineating potential 
effects on nontarget species. 
3) The application is limited to site-specific, well-defined 
subpopulations or populations. 
4) The application does not alter the gene pool of the 
species. 
5) Short- and long-term effects on population dynamics, 
including age structure and behavioral effects, are 
evaluated through modeling and monitoring. 
6) The program is evaluated by regulatory and wildlife 
management agencies before use, with full public 
participation. 
7) Costs of the fertility control program are borne by the 
organizations or public that benefit from the program. 
The position of the AAWV reflects most of the concerns of 
both wildlife managers and the general public regarding use 
of contraception to manage wildlife populations. 
The purpose of this technical review is to summarize past 
wildlife contraception efforts, discuss the current state of 
research and where the research is headed, and examine the 
feasibility of field use for contraceptives. Specifically, can 
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the techniques proposed be used safely, economically, and 
within legal state and federal mandates? Many contentious 
issues have been raised regarding use of infertility agents for 
managing wildlife populations (Bomford 1990). The 
following sections will address each of these issues, 
followed by a review of the current status of wildlife fertility 
control products. A list of acronyms is provided in Table 1. 
BIOLOGICAL FEASIBILITY 
The use of infertility agents to control populations of wild 
animals may offer an alternative to the use of population 
reduction by increasing mortality However, whether 
fertility control is biologically feasible for a particular 
species and population depends on a number of parameters 
(Curtis et al. 1997a, Nielsen et al. 1997). including whether 
the population is "open" or "closed," population numbers, 
sex ratios, age structure, and estimated rate of increase and 
mortality of the concerned species. Also required is an 
estimate of the number of animals in the population that will 
require treatment and for how long. 
Dolbeer (1998) used population models to compare the 
relative efficiency (i.e., % decline in population size relative 
to number of animals sterilized or removed) of reproductive 
control and lethal control in managing wildlife populations. 
The predicted relative efficiencies of lethal and reproductive 
control for various wildlife species (Table 2) can be 
generalized based on adult survival rate (ASR) and age at 
which animals reproduce. For species in which females first 
reproduce at 1 and 2 years, lethal control will be more 
efficient than reproductive control in reducing populations 
when the ASR is greater than about 0.56 and 0.23, 
respectively. For species in which females first reproduce at 
3 years, lethal control always will be more efficient than 
reproductive control in reducing populations. In general, 
this means that reproductive control will be most effective in 
managing smaller wildlife species such as black rats (Ratrus 
rarrus), brown-headed cowbirds (Molothus ater) and red- 
billed quelea (Quelea quelea) with high reproductive rates 
(i.e., reproducing at early age, large litter or clutch size) and 
low survival rates. Knipling and McGuire (1972) developed 
a theoretical model demonstrating that if 70% of male and 
female rats could be sterilized for three generations (1 year) 
the entire population would be eliminated. 
Conversely, reproductive control will be much less efficient 
than lethal control in managing populations for larger 
species such as deer (Odocoileus spp.), coyotes (Canis 
latrans), Canada geese (Branra canadensis), and gulls 
(Lams spp.) that do not typically reproduce until 2-4 years 
of age and have smaller litter or clutch sizes than most 
rodents and small buds. These population simulations 
(Dolbeer 1998) demonstrated that for many wildlife species 
in need of population management, such as deer and Canada 
geese, lethal control will be more efficient than reproductive 
control in reducing population levels. For example, in 
white-tailed deer, which have a low reproductive rate and a 
life span from 10 to 12 years, fertility control alone will 
probably not be effective in reducing the population. With 
an estimated annual mortality rate of 20% for roadkill and 
other losses, a deer herd treated only with contraceptives 
would remain at a high population level for several years 
after initiation of a contraception program. From a practical 
standpoint, it would be better to reduce the deer berd to a 
desired number by some other management technique, then 
apply fertility control to stabilize berd growth (Nielsen et al. 
1997). The proportion of deer that would have to be treated 
with fertility control agents would depend on average 
reproductive rates and the female age structure of the herd. 
Curtis et al. (1998) used 4 years (1993-96) of culling data 
from the Irondequoit, New York deer herd to study the 
biological feasibility of contraceptive applications. The 
age and sex structure of the population was simulated using 
an automated program for reconstructing deer populations 
(Moen et al. 1986). The program established an initial 
breeding population of the size necessary to support 
human-related mortality (i.e., culling, deer-vehicle 
collisions), and natural deer mortality with a biologically 
reasonable sex and age structure. Simulated annual 
reproduction and losses contributed to changes in the sex 
and age structure in successive years. This simulation 
produced an initial preculling population size of 905 deer 
in 1993, and fall deer populations in subsequent years of 
852,702, and 457 deer for 1994-96, respectively (Curtis et 
al. 1998). Next, the number of females culled each year 
was divided by the weighted mean reproductive rate for the 
population to determine the number of females that would 
have to be treated with fertility control agents to remove 
their potential fawns from the population; the number of 
females to be treated was twice the number culled because 
of the ma1e:female fawn sex ratio. The total was divided 
by 0.89 to account for the 89% efficacy observed for 
contraceptive vaccines delivered via dart gun. The 
proportion of female deer in the simulated population that 
required treatment in any given year varied from 29-100% 
(Curtis et al. 1998). This wide variation was directly 
related to the number of female deer culled in relation to 
changing deer numbers and shifts in the population age and 
sex structure over time. In 1 year, more females in the 
simulated herd required treatment with contraceptives than 
were actually available. This example raises concerns 
about the biological feasibility of wildlife fertility control 
in long-lived species when agents are delivered via dart 
rifle. 
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From the perspective of population dynamics, efforts for 
developing infertility agents to manage wildlife populations 
should focus on those species for which the concept is most 
likely to be successful, such as rodents and small birds. Thls 
finding conflicts with the growing public desire for nonlethal 
methods such as reproductive control to solve human- 
wildlife conflicts in larger, long-lived species. Furthermore, 
if infertility agents are developed and used on long-lived 
species such as deer and geese, biologists need to be honest 
with the public about the inefficiencies of this approach and 
the length of time required for such strategies to reduce 
populations relative to lethal control. 
PUBLIC ATTITUDES TOWARD 
WILDLIFE FERTILITY CONTROL 
AGENTS 
Changes in sociopolitical values have resulted in more of the 
public wanting to he included in wildlife management 
decisions today than at any other time since the advent of 
applied wildlife management in North America (Curtis and 
Richmond 1992, Curtis et al. 1997). Citizens want to 
participate in setting objectives for management and in 
approving the methods for accomplishing those objectives. 
The decision-making process is no longerjust a decision 
made by the manager. Today's decision must bring together 
all concerned parties-federal, state, private citizens, and 
special interest groups. Whether we call this process 
"stakeholder groups," "citizen task forces," "committee 
action groups," or "human dimensions," it is a break from 
the traditional way of managing wildlife. Wildlife 
management agencies are now working within a new 
paradigm for management that strives to integrate the 
biological and human dimensions of wildlife management 
for improved decision making (Decker et al. 1992). This 
contemporary paradigm recognizes that decision making 
occurs in an environment with sociocultural, economic, 
physical, legal, and administrative aspects, as well as 
biological components (Decker et al. 1992, Slate et al., 
1992). Agencies recognize that people representing a variety 
of views are legitimate stakeholders in management, and the 
public is demanding to have their concerns addressed--one 
of which is that managers seek nonlethal means for the 
management of wildlife. Nowhere is this more evident than 
in the area of wildlife contraception as a potential 
management tool. Gill (1993) stated that "given the nature 
and potential polarity of the wildlife contraception issue, 
wildlife agencies will have to behave proactively by 
projecting themselves into their future." Kania and Conover 
(1991) emphasized that wildlife agencies should respond to 
these societal changes rather than resist them, thus 
enhancing the value of the wildlife resource for all people. 
In fact Schmidt (1992) argued that natural resource 
management decisions, previously thought to be defined by 
science and economics, are now driven by human values. 
The purpose of this discussion is to describe public 
involvement in wildlife management decisions with 
particular reference to wildlife fertility control. Because few 
studies have focused on identification and explanation of 
people's beliefs and attitudes toward wildlife fertility 
control, the public involvement aspects are reviewed in 
detail. 
Public Involvement Strategies for Making Wildlife 
Management Decisions 
Sanhorn et al. (1994) conducted a survey of 134 state, 
regional, and national agencies and organizations in the 
United States, and determined that most lacked a policy 
relating to contraception in wildlife management. Only 9% 
of state wildlife agencies had an established policy, 
compared to 39% of 54 environmental and animal activist 
groups. Sanborn et al. (1994) also indicated that the first 
step in gaining public acceptance of wildlife fertility control 
is to convince the public that this is a viable wildlife 
management tool. None of the groups surveyed indicated 
that wildlife fertility control was a practical management 
option at that time. 
Beliefs and values that influence the acceptability of wildlife 
fertility control should be considered early in the research 
and development process, before too much time and money 
are invested in approaches that may later prove to be morally 
or ethically unacceptable. For example, Turner et al. (1992) 
noted that female white-tailed deer treated with a porcine 
zona pellucida (PZP) vaccine continued to exhibit estrous 
cycles after not becoming pregnant. These changes in deer 
reproductive biology, and their potential to change behavior 
and energetics, could raise ethical and management 
questions, and may inkluence stakeholders' perceptions of 
this contraceptive technique. Stakeholders must understand 
the full range of effects that different contraceptive methods 
may have on wildlife populations before making decisions to 
accept or reject their use. 
People's beliefs and attitudes about wildlife are formed, 
exist, and change in a context of broader attitudes and values 
concerning several domains of their lives. Wildlife- 
associated attitudes and values also are related to other 
major world views, such as appropriate human interaction 
with the environment, religious beliefs, beliefs about safety 
and security of family and community, and beliefs about 
individual freedom of choice in dealing with problems (i.e., 
those caused by wildlife). Based on studies by the Human 
Dimensions Research Unit in the D e p m e n t  of Natural 
Resources at Cornell University, a Wildlife Attitudes and 
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Values Scale (Purdy and Decker 1989) was developed and 
applied in over a dozen situations. This work identified the 
existence of three broad dimensions of public attitudes 
toward wildlife: wildlife use, wildlife preservation, and 
wildlife damagelnuisance tolerance. The attitudes and 
beliefs toward wildlife damagelnuisance tolerance vary 
widely. Tnresholds exist for tolerance of wildlife-caused 
problems depending upon economic or health and safety 
risks. For example, some people will incur high levels of 
economic losses from wildlife before they find the tradeoff 
tips toward damage abatement or lethal control. However, 
when the perceived risk of health and safety problems 
associated with wildlife (e.g., rabies, Lyme disease, motor 
vehicle accidents, etc.) reach even modest levels, tolerance 
of wildlife causing the risk is reduced markedly (Stout et al. 
1993). It is likely that people will change their attitudes 
toward fertility control if perceived risks of economic loss, 
or health and safety impacts, exceed tolerance thresholds. 
Increasingly the wildlife management profession is finding 
that public-involvement techniques are helpful in reaching 
community consensus on controversial wildlife management 
issues (McAninch and Parker 1991, McMnllin and Nielsen 
1991, Nelson 1992, Curtis et al. 1993, Stout et al. 1993). If 
conceived carefully and implemented effectively, citizen 
participation strategies present educational opportunities, 
improve the agency image as being responsive to 
stakeholder needs, and lead to more acceptable decisions 
and actions to solve management problems (Stout et al. 
1993). Several models have been used to involve citizens in 
wildlife management decisions (McAninch and Parker 1991, 
Curtis et al. 1993), and these may be adapted to fit other 
situations. In a New York deer contraceptive study, the work 
of citizen task forces was greatly enhanced by the 
availability of systematically collected human-dimensions 
data gathered from the community at large and from 
members of specific stakeholder groups. Evaluation of 
participants involved with ongoing task forces can improve 
communication and is invaluable for effectively managing 
the process (Stout et al. 1992). 
Involving communities in wildlife management decisions 
has led to the evolution of comanagement (Schusler 1999), 
which was defined by the World Conservation Congress in 
1996 as "A partnership in which governmental agencies, 
local communities and resource users, nongovernmental 
organizations, and other stakeholders share, as appropriate to 
each context, the authority and responsibility for the 
management of a specific tenito~y or set of resources." 
Proponents of comanagement believe it is more appropriate, 
efficient, and equitable than more conventional government 
control. An example of a comanagement approach is deer 
contraception research in the Town of Irondequoit, NY, 
where funding and political support were provided by the 
New York State Deparunent of Environmental Conservation 
(through a direct, line-item appropriation from the New York 
State Legislature) as well as by the local community. 
Identifying Public Acceptance of Wildlife Fertility 
Control 
Wildlife managers considering the use of contraception for 
resolving wildlife problems need knowledge of the specific 
attitudes held by stakeholders in a given management 
situation. Currently, insufficient research is available that 
describes public attitudes toward wildlife fertility control. 
The Town of Irondequoit was selected as the site for an in- 
depth study because of a long-standing deer-management 
controversy surrounding Durand Eastman Park and 
implementation of a public involvement process for setting 
deer management objectives (Curtis et al. 1993). In 
addition, the NY Department of Environmental Conservation 
and the College of Environmental Science and Forestry at 
State University of New York are conducting an 
experimental field application of fertility control vaccines in 
this community (Nielsen et al. 1997). 
To learn about public attitudes toward deer management 
alternatives in Irondequoit, a mail survey of property owners 
was conducted (Lauher and Knuth 1998). The survey 
included several questions concerning contraceptive 
management of a locally overabundant deer herd. The 
questionnaire was sent to 1,494 Irondequoit residents, and 890 
useable responses were received. The community was 
divided on the preferred approaches for managing the deer 
herd. About 27% of respondents supported contraception, 
24% supported lethal control (e.g., bait and shoot), 18% 
wanted trap and transfer of deer, and 13% supported other 
nonlethal approaches (Lauber and Knuth 1998). Compared to 
respondents who favored lethal control, people who supported 
deer contraception placed a higher emphasis on humaneness, 
protecting other wildlife and pets, minimizing violence, and 
choosing politically acceptable methods. Contraception 
supporters perceived this technique to be more effective and 
reliable, faster, less expensive, more humane, and more 
widely supported in the community than residents who 
supported other deer management methods. For respondents 
who opposed contraception, maximizing hunting oppomnity 
and speed in reducing the size of the deer herd were more 
important considerations. Respondents who supported lethal 
control also wanted to minimize management costs (Curtis et 
al. 1997). Respondents who were interested in increasing 
deer-hunting opportunities and reducing economic costs 
generally were opposed to contraception. 
Community support for any deer management action, lethal 
or nonlethal, will require significant public education (Stout 
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et al. 1997), and it may be necessary to build consent for 
management among several stakeholder groups with 
divergent viewpoints (Curtis and Hauber 1997). Addressing 
the social conflicts associated with overabundant wildlife 
may be much more difficult than managing the biological 
aspects of population management. 
POLICY AND THE DECISION- 
MAKING PROCESS 
FederaYState Agency Management 
Hunting and trapping traditionally have been the primary 
management tools for controlling populations of many 
species of wildlife. During the past 20 years, changes in 
wildlife distributions and density have increased the 
frequency of human-wildlife interactions in the urban- 
suburban environment and in city, county, state and federal 
park lands where regulated public hunting or trapping are 
not permitted by law. As a result, managers are seeking 
alternative means to manage wildlife, and use of 
contraceptives increasingly is being advocated as a wildlife 
management tool. 
What Information Is Needed Prior to Wildlife 
Contraception? 
Prior to implementation of any wildlife contraception 
program, managers need to have a considerable amount of 
information/data at their disposal to aid in the decision 
process. A paramount piece of information required is the 
legal status of a species and site. In general it is the state 
and federal agencies that have primary responsibility for the 
management of wildlife. Each branch of the federal 
govemment and each state and local government has a 
unique set of statutes and regulations (Guynn 1997) that may 
be applicable and that managers must be aware of prior to 
implementing a wildlife contraceptive program. These 
include the FDA regulatory requirements and permits for use 
of the contraceptive; field use of a contraceptive must occur 
under an Investigational New Animal Drug (INAD) permit 
or  a New Animal Dmg (NAD) authorization. If the 
contraceptive project is conducted on federal lands, uses 
federal funds, or is conducted by federal employees, the 
National Environmental Policy Act (NEPA) requires that the 
action be evaluated for potential adverse impacts on humans 
and the natural environment. Depending on the scope of the 
contraceptive project, the project may require an 
Environmental Assessment or an Environmental Impact 
Statement or can be "categorically excluded" (actions do not 
have a significant effect on the quality of the human 
environment and do not require an Environmental 
Assessment of an Environmental Impact Statement). When 
the project involves bird species protected under the 
Migratory Bird Treaty Act, the U.S. Fish and Wildlife 
Service (FWS) must be contacted prior to use of an 
antifertility agent. If potential exists for an endangered 
species to be exposed to the agent, a consultation with the 
FWS may be required by the Endangered Species Act. 
Activities involving resident wildlife (i.e., those protected by 
state laws) are regulated by the respective state agencies and 
require appropriate authorizations. There also are state- 
specific environmental policy/protection laws and 
regulations, state laws relating to the conditions and use of 
drugs andlor vaccines, and other state wildlife and public 
health requirements. Additionally, other local laws and 
regulations often place further restrictions on management 
activities. 
Wildlife management in the United States and the methods 
used for management of wildlife and of certain nonwildlife 
species (i.e., wild horses [Equus caballus], feral burros 
[Equus asinus], and bison [Bison bison]) are largely 
dependent on the management goals and objectives of the 
agency with delegated legal management authority. The 
goals and objectives of management may vary among states 
and among federal agencies. To further confuse the issue, 
management authority and the responsibility for 
implementing management actions may vary, with one or 
more bureaus, departments, or agencies having responsibility 
within each state or the federal govemment. The question of 
land ownership adds even greater confusion; lands can be 
owned by cities, counties, states, federal agencies or private 
citizens. In the case of game farms, there also is a question 
of whether or not certain wildlife is publicly or privately 
owned. 
Therefore the first question to be asked before a 
contraception program is implemented is "Who has the 
authority over this group of animals?" Once that is 
established, the specific goals and management objectives of 
the contraceptive program must be clearly defined and 
aticulated, i.e., why are we doing this and what is it that we 
want to achieve? Caugbley and Sinclair (1994) suggest 
answering the following questions: Where do we want to 
go? Can we get there? Will we know when we have 
arrived? How do we get there? What disadvantages or 
penalties accrue? What benefits are gained? Will the 
benefits exceed the penalties? 
Tools Available to Aid in the Decision Process 
As stated above, management policies, goals and objectives 
differ from agency to agency. Generally, agency policies are 
couched in broad terms that provide little more that a 
general guide for managers. Goals provide ideal ends or 
effects and give direction and purpose; they provide limits to 
the range of potential objectives. Objectives are statements 
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of specific conditions to be achieved. In considering what 
goals or objectives are appropriate, managers must consider 
social, political, biological and economic factors. Although 
consensus on agency management policies, goals, and 
objectives may not he possible, consent may he obtainable 
(Curtis and Hauber 1997). We recommend that as an aid in 
the decision process managers prepare an objective-action 
matrix in which possible objectives are ranked against 
feasible actions to determine how each action is likely to 
meet each objective (Norton 1988). Managers can then 
assess whether or not an objective can be met by each action 
of a particular management problem. Another matrix that 
managers may use to aid in the decision-making process is 
one examining possible management actions against criteria 
of feasibility (Bomford 1988). These matrixes will assist 
managers in determining whether the use of wildlife 
contraceptives as a management or research action is 
technically and biologically feasible, and socially, politically, 
and economically acceptable. If feasible and acceptable, can 
all the legal, regulatory, and permit requirements be met, and 
can the goals and objectives of the agency he met? 
Managers could consider using a decision and alternative 
key (Coffey and Johnston 1997) developed using an 
integrated pest management (IPM) approach for managing 
white-tailed deer. The IPM alternative management 
approach uses problem-solving based on identified or 
suspected ecological, economic, sociological, and political 
consequences. The process starts with clearly defined goals 
and ohjectives for management and a decision key provides 
a guide for managers to ensure that specific and necessary 
actions are completed. A "No" answer to any question 
precludes going to the next step until the previous step or 
action is completed. Once the decision key has been 
completed, managers proceed to the alternative key, which 
provides for a selected list of alternatives ranging from those 
that have the least ecological, economic, sociological, and 
political impacts to those that are the most difficult to 
implement. In most cases wildlife contraceptive problems 
may he resolved by combining alternatives or components of 
alternatives and by cooperating with other federal, state, and 
local agencies, and the private sector. 
REGULATION OF WILDLIFE 
CONTRACEPTION DRUGS 
An unapproved new animal drug is unsafe within the 
meaning of Section 512 of the Federal Food Drug and 
Cosmetic Act (FFDCA). It is illegal to transport unapproved 
drugs in interstate commerce. Therefore, it will be 
necessary to gain approval of wildlife contraception drugs 
intended to curtail population growth of "nuisance" wildlife. 
Veterinary drugs are approved by the Center for Veterinary 
Medicine of the Food and Drug Administration 
(CVM/FDA). As defined by the FFDCA, drugs are "articles 
intended for use in the diagnosis, cure, mitigation, treatment, 
or prevention of disease in man or other animals; 
and...articles (other than food) intended to affect the 
structure or any function of the body of man or other 
animals ...." Veterinary biological products, which are "for 
use in the diagnosis, treatment, or prevention of diseases in 
animals," on the other hand, are licensed by the 
Biotechnology, Biologics and Environmental Protection of 
the Center for Veterinary Biologics of the Animal and Plant 
Health Inspection Service (APHIS) of U. S. Deparunent of 
Agriculture (USDA) under the Virus, Serum, Toxin Act 
(1913). Pregnancy is not considered a disease; therefore, 
development of products, including vaccines, for this 
indication falls outside of USDA jurisdiction. Likewise, 
regulation of animal drugs falls outside jurisdiction of the 
Environmental Protection Agency (EPA). EPA is 
responsible for regulating pesticides under the Federal 
Insecticide, Fungicide, and Rodenticide Act (F'IFRA). 
Regulations regarding the investigational use of new animal 
drugs are set forth in 21 Code of Federal Regulations 
(CFR) 51 1 and the regulations describing the new animal 
drug application are set forth in 21 CFR 514. The process 
begins with the establishment of an Investi~ational New 
Animal Drug (INAD) exemption. This allows for the 
interstate nansport of an unapproved new animal drug for 
use in safety and effectiveness studies conducted to support 
the drug's approval. To support a new animal drug 
approval, a drug sponsor must provide substantial evidence 
of a drug's effectiveness through adequate and well 
controlled studies. The safety of the drug in the target 
species also must be proven. In addition, the drug must be 
manufactured under Good Manufacturing Practices of FDA 
to assure its identity, strength, quality, and purity from 
batch to batch. Environmental, human food, and user 
safety issues also must he addressed. Finally, a suitable 
label is produced and a Freedom of Information Summary 
(required by FDA) written. The new animal drug approval 
process can take several years depending on the quality of 
the information submitted to support the drug's approval, 
the time needed to generate that information, and the status 
of the manufacturing facility employed to manufacture the 
drug. 
CVM/FDA recognizes that novel approaches to the approval 
of wildlife contraceptives may be necessary because of 
public ownership of wildlife, intrinsic value of such animals 
to society, and the difficulty in collecting data under less 
than ideal conditions. However, the current standards for 
approval of wildlife drugs, including contraceptives, are 
identical to those for other new animal drugs. As noted 
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above, drugs approved for wildlife contraception must be 
labeled according to FDA regulations and policies. These 
drugs will most likely bear an "Rx" or prescription legend, 
thereby limiting use by or under the direction of a licensed 
veterinarian for several reasons. These include the special 
training that may be necessary to ensure the humane 
treatment of the animals (i.e., knowledge of darting, 
trapping, and other capture methods) and the possible danger 
to the person administering the product if it is not handled 
properly. Furthermore, the "Rx" status may limit the 
adverse impact on the environment and will provide controls 
to minimize the potential for inappropriate usage. CVM 
may consider allowing those involved in the practice of 
wildlife management to use the drugs also. All new animal 
drugs are monitored postapproval for the occurrence of 
adverse events. Appropriate labeling changes are made, if 
necessary. 
Anyone can sponsor a drug approval package. However, 
sponsors are generally pharmaceutical firms because of the 
monetary resources needed to conduct safety and 
effectiveness studies and to maintain acceptable chemisuy 
and manufacturing standards. Nevertheless, multiple 
organizations may work together in drug development to 
meet FDA requirements. There are currently no fertility 
control agents for wildlife that have received approval by 
FDA and that are commercially available in the U.S. 
ECONOMICAL PRACTICALITY 
In addition to being biologically feasible for reducing 
populations of the mget species, infertility agents will need 
to be economically practical to use. The economic 
practicality involves development and authorization of the 
contraceptive drug, as well as assessment of all costs of 
treatment including personnel, equipment, contraceptive 
vaccines, and other equipment and supplies. 
Product Development 
The cost of obtaining authorization by the FDA can be very 
high for use of new infertility drugs such as conuaceptive 
vaccines. A survey developed by the Animal Health Institute 
(Mark Wood, Animal Health Institute, personal 
communication) indicated that companies average 11 years 
and spend an average of $22 million to develop and bring a 
new animal drug to market. The cost and time of 
development are less (about $2 million and 4.5 years) for 
new veterinruy biologicals, but still are high. These high 
costs may prevent the majority of infertility agents from 
being developed commercially, because profits are not large 
(87% of all animal drugs have individual sales of less than 
$1 million a year), and wildlife are only a minor portion of 
the animal drug market. Infertility agents targeting potential 
food species, such as deer and geese, will potentially cost 
more to register than those targeting nonfood species 
because of concerns for human safety. A company 
interested in developing a wildlife infertility agent must 
compare the developmental costs to the eventual monetary 
returns. The more radical the product (e.g., a recombinant 
bacteria delivering a contraceptive vaccine) the higher the 
cost for registering the product. Research is increasingly 
focusing on products already licensed by USDA or FDA for 
other purposes. An infertility agent that has already passed 
FDA scrutiny for its proposed use (such as a commercial 
agricultural product) will cost less to develop as an approved 
product for contraceptive use. Examples include LutalyseB, 
which is an FDA-approved drug for synchronizing estrus 
and terminating pregnancy in several species of animals used 
for human food, but which also is a potential fertility control 
agent for white-tailed deer (DeNicnla et al. 1997b), and 
nicarbazin, an FDA-approved drug for the control of 
coccidiosis in broiler chickens, but which is being tested as a 
fertility control agent for pest species of birds. 
There are currently no fertility control agents for wildlife 
that have received approval by FDA and are commercially 
available in the U.S. Several agencies and organizations 
currently hold INAD exemptions allowing interstate 
transport of the unapproved drugs for use in studies to 
support the safety and efficacy of those drugs. For example, 
research is beiug conducted by the USDA under INAD 
exemption numbers for Gonadotropin-Releasing Hormone 
(GnRH) and Porcine Zona Pellucida (PZP) immunoc- 
ontraceptive vaccines, for the cholesterol inhibitor 
DiazaCon, and for the avian reproductive inhibitor, 
nicarbazin. All are classified as investigational drugs. 
Cost of Implementing Fertility Control Programs 
Immunocontraceptive Vaccines 
Although infertility agents may show effectiveness in 
laboratory or pen situations, economical methods of 
manufacturing and delivering the agent to the animals are 
needed before they will be widely used. A potential hurdle 
in the development of a zona pellucida contraceptive vaccine 
is the difficulty in purifying sufficient quantities of the 
protein, making the cost of the vaccine high (about $50 per 
dose); large scale production could potentially be achieved 
through recombinant DNA technology and genetic 
engineering. Also, use of currently available 
immunocontraceptive vaccines is costly, because they 
require both an initial dose and a subsequent booster dose to 
achieve adequate contraceptive effect, and annual booster 
inoculations may he required. Presently the vaccines are 
injectable only by hand or by a biobullet or dart gun. These 
remote delivery systems have certain advantages (Kreeger 
1997): (1) they target specific animals; (2) they can 
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administer a dose on a body weight basis; and (3) they can 
deliver solid, semisolid, or liquid formulations. However, 
they also have inherent disadvantages: treatment cost is 
high; personnel must locate and approach target animals; 
they can be used only on large animals; and they are 
complex, noisy and require experienced personnel to 
employ. 
The current vaccines also use Freund's adjuvant; because of 
concerns by FDA about the safety of this adjuvant, huntable 
animals must be eartagged with a "Do Not Consume" 
notice. Turner et al. (1997) found that a Zinjection protocol 
presented logistical and economic problems for use in feral 
horses because of the need to keep horses gathered together 
for 3 4  weeks to give a second injection. They estimated 
that a single injection with the current PZP vaccine would be 
effective in only about 2&28% of the vaccinated horses in 
the first year. After a booster in subsequent years they 
estimated that efficacy should increase to about 90%. Curtis 
et al. (1998) also demonstrated that the 2-shot paradigm of 
vaccinating deer (and ear tagging as required by the FDA for 
current products) is too labor intensive and costly to be a 
practical solution for reducing deer populations. During the 
field study of PZP and GnRH vaccines in New York State, 
183 deer were captured and tagged at an average cost of 
$136ldeer for fuel and equipment, and 11.2 hrsldeer for 
labor, which totaled about $250 for each deer marked (Curtis 
et al. 1998). Capture and marking accounted for about 28% 
of the estimated program costs. Costs to administer 
contraceptive vaccines to a herd of about 300 deer were 
approximately $80,000 per year. 
A single-shot, dart or biobullet-delivered vaccine is needed 
to make immunocontraception programs economically and 
logistically feasible. Research currently being conducted 
cooperatively by the National Wildlife Research Center of 
APHIS and Pennsylvania State University has demonstrated 
that a single-shot PZP vaccine mixed with a newly 
developed adjuvant and delivered to deer by dart or biobullet 
may effectively cause infertility in deer, possibly for 
multiple years. The new adjuvant also may eliminate the 
requirement that vaccinated deer be ear-tagged, making 
immunocontraception using PZP a feasible approach for 
some sites. Brown et al. (1997a) tested a single shot PZP 
vaccine called SpayVac on gray seals (Halicoerus glypus) 
and suggested the single-shot vaccine may be effective for 
multiple years. 
Even with capture and tagging costs removed, however, 
funding for labor and vaccine expenses in the New York 
deer study still totaled more than $180,000 over 4 years. 
According to the Comell simulation, more than 400 female 
deer would require multiple vaccine treatments to match the 
effects of culling. A field study conducted to determine the 
actual feasibility of using contraceptive vaccines to regulate 
numbers of free-ranging deer (Nielsen et al. 1997, Rudolph 
et al. 2000) in Irondequoit, indicated that, at least for deer, it 
will be extremely expensive to treat enough individuals to 
regulate population growth as long as fertility control agents 
need to be delivered by dart-gun to individual animals. And 
if the problem associated with the deer herd is serious, a 
contraceptive program may not reduce that problem quickly 
enough, as all the adult deer are still present. As indicated 
above, it may be preferable to cull a herd to a goal 
population size, then dart a portion of the remaining females 
with contraceptive vaccines to inhibit or slow herd growth 
(Nielsen et al. 1997). If a community decides to use 
conrraceptive vaccines to control deer numbers, it needs to 
realize this requires a long-term commitment of funding and 
personnel and careful planning to ensure that the fiscal and 
human resources are available to support the work over the 
long term. 
Oral Deliverv of Immunocontraceptive Vaccines 
There are 2 facets to drug delivery that present challenges to 
wildlife managers-getting the agent into the animal, and 
controlling its release to maximize efficacy. The methods of 
delivery may need to be as varied as the species targeted, 
because no single technology will be able to satisfy all the 
concerns of efficacy, economics, and animal and human 
safety. A practical and cost-effective means to deliver a 
vaccine to some populations of free-roaming animals is by 
oral delivery (Miller 1997a). However, oral delivery is a 
difficult technology to develop and would increase the 
USDA and FDA regulatory involvement because it is a new 
and unproven technology. There also would be a need to 
prove that oral vaccines are safe in the environment and that 
they will not adversely affect nontarget species. Although 
there is a great need in third world countries for human oral 
vaccines because of the lack of physicians to administer 
injectables, little money is currently being spent by drug 
companies on oral vaccine research. Because much of the 
technology wildlife researchers use comes from human 
infertility studies, it is not expected that oral 
immunocontraceptive vaccines will be available soon. 
The ideal oral delivery system will need the ability to 
(1) survive the acidic stomach, (2) be taken up into the 
bloodstream from the intestines, and (3) cause a strong 
immune response (Mestecky and McGee 1989, McGhee et 
al. 1992, Walker 1994). Live microorganisms such as 
attenuated (noninfective) forms of Mycobacrerium bovis , 
Kbrio cholerae, some strains of Salmonella, and E. coli 
have some of these properties (Atuidge et al. 1997) and 
could be coupled to contraceptive vaccines. In a live viral 
vector, inserted DNA would synthesize the vaccine protein 
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as the virus multiplied in the host animal, thereby 
vaccinating the host animal. In a bacterial vector, a 
recombinant bacteria genetically rendered hamless could 
deliver an immunocontraceptive protein. Attenuated 
Bacilllcr calmette guerin (BCG) bacterium (which is widely 
used as an oral tuberculosis vaccine in its nonrecombinant 
fonn) and double gene-deleted Salmonella typhi bacillus are 
considered safe, are economical to produce, and are used in 
human vaccine delivery applications. However, there have 
been few field uses of recombinant bacterial and viral 
vectors. Oral vaccination of wildlife is currently being used 
in the U.S. to halt the spread of rabies in wildlife 
populations in Texas and in the northeastern states using a 
vaccinia virus genetically engineered to deliver a rabies 
vaccine. And Miller et al. (1999~) demonstrated the 
laboratory feasibility of oral vaccination using the BCG 
bacterium. There is considerable reluctance in the U.S. to 
use a live vector to deliver a contraceptive vaccine; thus, 
little research is being conducted in this area. 
In contrast to U.S. researchers, scientists in Australia and 
New Zealand are looking at self-sustaining infectious 
biological vectors such as genetically modified myxoma 
viruses (Tyndale-Biscoe 1997), bacteria, or nematodes to 
spread contraceptive vaccines. This approach has raised 
widespread concern from the public and from other 
countries because of the difficulty in containing the 
infectious vector, a difficulty underscored by the recent 
spread of rabbit calicivhs from an island quarantine area to 
the Australian mainland. There are a number of issues 
regarding the international consequences of introducing an 
agent designed for a species that is a pest in one country but 
a desirable species in another. A recent development in 
Australia raises an additional concern about genetically 
manipulated infections vectors (Nowak 2001). As part of a 
study aimed at creating a contraceptive vaccine, researchers 
from Australia's Commonwealth Scientific and Industrial 
Research Organization (CSIRO) and the Australian National 
University inserted into a mousepox virus a gene that 
creates large amounts of interleukin 4 (IL-4), a molecule 
that occurs naturally in the body. The mousepox virus 
provided the oral delivery system for the vaccine and the 
gene for IL-4 was added to boost antibody production. 
Surprisingly, the modified virus totally suppressed the 
immune response to the mousepox virus. Although 
mousepox normally causes only mild symptoms, with the 
added IL-4 gene it became lethal; the engineered virus also 
appeared unnaturally resistant to attempts to vaccinate the 
mice. 
Because of the concerns of releasing bacterial and viral 
material into the environment, APHISIUSDA is researching 
inserting contraceptive vaccines into baker's yeast, and other 
scientists are researching the use of genetically engineered 
plants as vectors (Arntzen et al. 1994, Greenhouse et al. 
1999). Although both of these technologies are in the initial 
research phase, they have the potential to provide a safe 
vaccine delivery system. These technologies could 
theoretically be used to grow the vaccine in the laboratory; 
the vaccine then could to be delivered as an expressed 
contraceptive protein or in oral form. 
The use of encapsulation may potentially provide acceptable 
oral delivery of vaccines by protecting the protein vaccine 
from the harsh environment of the stomach. Synthesized 
vectors, such as biodegradable microspheres (slow release 
antigen-delivery systems), and liposomes (spherical, 
artificial lipid membranes), can theoretically protect the 
vaccines and deliver them to the mucosal immune cells. 
Researchers (Alving et al. 1986, Holmgren et al. 1993, 
Homquist et al. 1994) have synthesized liposomes (lipid 
membranes) that incorporate bacterial receptors that promote 
binding to the intestinal epithelial cells. Contraceptive 
vaccines can potentially he delivered to the bloodstream 
while encapsulated in these liposomes. Miller and 
Fagerstone (2000) tested an adhesive liposome containing a 
GnRH immunocontraceptive as an oral vaccine in wild 
Noway rats. They achieved an inconsistent oral response, 
with 50% percent of the rats showing antibody titers and a 
significant reduction in senun testosterone, but the other 
50% showing no antibody titer. 
Oral Deliverv of Chemical Contraceptives 
Chemical contraceptives such as steroids and nicarbazin can 
be delivered orally in a bait. The problem with this method 
of delivery is getting adequate bait acceptance. An example 
of the difficulty in developing an adequate delivery system 
for wildlife is the development of nicarbazin for infertility 
control for Canada geese. Canada geese are monogamous 
and territorial during the breeding and nesting season, 
making this species vulnerable to induced infertility 
(Kemelly and Converse 1997). When fed on a regular basis, 
nicarbazin reduces hatchability of eggs. In many areas, 
urban geese are accustomed to being fed, so it was assumed 
that development of a nicarbazin bait to be fed regularly 
during the breeding season would be relatively easy. 
However, the nicarbazin has an astringent taste that geese 
find aversive, so its taste must be masked to achieve 
adequate consumption. Also, geese during the nesting 
period go from group feeding to individual feeding around 
nests and from grains to green grasses, so it is difficult to get 
a product to them consistently and in sufficient amounts. A 
controlled-release system such as a grit treated with 
nicarbazin may be required to deliver a product to this 
species, which would further increase the difficulty and cost 
of developing an effective contraceptive product. 
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HEALTH AND SAFETY ISSUES 
Health Effects on Target Animals 
One of the issues faced by policy makers when making 
decisions on whether infertility agents are a reasonable 
approach for wildlife population control will be effects of 
contraceptives on the health of the target species (Guynn 
1997). Effects on the target species include not only the 
physiological effect of the contraceptive on individuals, but 
also how the treated individuals affect the dynamics of the 
population. These data are difficult to obtain because 
wildlife do not lend themselves to intensive study as 
individuals or as populations. Nevertheless, studies will 
need to be conducted to define potential benefits and adverse 
effects. 
One issue of concern to wildlife managers is the reversibility 
of infertility agents. There is considerable disagreement 
among scientists regarding the advisability of reversibility, 
depending on the species targeted and the intended 
population effect. In some cases, such as with invasive 
species (nonnative exotics), an irreversible contraceptive is 
desirable. In other cases where yearly management 
strategies may be important, a short-term effect may be 
preferred. In many cases it would be an advantage if the 
contraceptive effect lasted several years but was then 
reversible to decrease risk of nontarget hazards and to 
increase management options. 
Most of the infertility agents discussed in this technical review 
are reversible. However, there is a large variation in the length 
of time that they are effective. Most of the steroid compounds 
need to be continuously fed to be effective-discontinuing 
feeding causes rapid reversibility. Other oral compounds 
(nicarbazin and DiazaCon) being studied as contraceptive 
agents must be fed frequently and do not have long-lasting 
effects. Therefore, developing methods to deliver these 
compounds efficiently to animals will be critical. Fortunately, 
many of the overabundant species that wildlife managers are 
concerned about are seasonal breeders in whch these short 
lasting compounds may be useful. The two immuno- 
contraceptive vaccines (PZP and GnRH) are both reversible, 
but after a longer period of time. The PZP vaccine can be 
effective for 1 4  years before the contraceptive effect wears off, 
whereas the GnRH vaccine is effective only for 1-2 years. 
The picture of how contraceptives affect overall animal 
physiology is far from complete. Data are needed from 
controlled studies of wildlife that have been treated with 
contraceptives to better understand how these agents may 
affect reproductive behavior, reproductive status, animal 
health and interactions among herd members. Observations 
should he made on individuals for periods of several years to 
better understand both the short and long-term physiological 
and behavioral responses that may occur as a result of 
contraceptive treatment. 
A number of adverse effects have been postulated for the use 
of chemical contraception and immunocontraception on the 
behavioral and physiological responses of wildlife (Table 3). 
These include potentially adverse effects on individuals, as 
well as adverse affects on populations, such as changes in 
the social hierarchy among males and females, feeding 
behavior, energy expenditure, local shifts in population, and 
increases or decreases in animal movement. What should be 
emphasized about many of the potentially adverse effects 
listed in the table is the word potential. For many of the 
effects, we lack sufficient data from controlled studies 
involving the wildlife species being treated with 
contraceptives. Often inferences are made from case studies 
of one or two animals, or from one species to another. In 
only a few studies have the potentially adverse effects been 
observed and their incidence quantified. Health data on 
treated individuals are available for some compounds and 
some species (Table 3) but are not widely available for all 
infertility agents. Nettles (1997) provided a comprehensive 
review of possible adverse health effects of infertility agents. 
The steroidal compounds showed potentially harmful effects 
on pregnant females, inhibition of parturition or dystocia, 
changes in ovarian function, impaired lactation, impaument 
of fertility of offspring, changes in secondary sex 
characteristics, and late abortions. However, a problem with 
assessing the information currently available is that it is 
often contradictory. For example, early reports using 
diethylstilbestrol (DES) for contraception have been 
associated with the potentially adverse affects listed in Table 
3 under chemical sterilants as reviewed by Nettles (1997). 
However, many subsequent studies using DES and other 
contraceptive sterolds administered via slow release 
subcutaneous implants or biobullets have found these to be 
effechve without adverse effects (as reviewed by Kesler 
1997 and Warren et al. 1997). 
Two of the few compounds for which health data are 
currently being gathered are the immunocontraceptive 
products PZP and GnRH. In two long-term immuno- 
contraceptive studies involving PZP and GnRH on white- 
tailed deer (Miller et al. 19996, Miller et al. 2000), animals 
were observed for reproductive behavior, animal health, 
interactions among individuals, hormonal status, antibody 
titers and other blood parameters, body measurements, and 
early pregnancy determjnation by ultrasound and later 
confirmation with fawning rates. These intensive studies of 
treated animals and controls have enabled a fairly complete 
picture of the physiological and behavioral response of the 
individual treatment. 
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GnRH immunocontraceptive treatments of white-tailed deer 
led to reduced progesterone concentrations, altered estrus 
behavior, contraception, failure to maintain pregnancy 
following conception, and reduced fawning rates (Miller et 
al. 2000). Infertility lasted up to 2 years without a booster 
injection. GnRH immunized bucks demonstrated no sexual 
activity when paired with control females. Depending on 
the immunization schedule, antlers either dropped early or 
remained in velvet. Necropsies of recently vaccinated deer 
showed that ovaries looked normal, although the GnRH 
vaccine did not block folliculogenesis in all ovaries as 
expected (F. Quimby and P. D. Curtis; Cornell Univ., 
personal communication). 
Numerous studies have been conducted on use of PZP 
(Turner et al. 1996, 1997; McShea et al. 1997; Warren et al. 
1997; Miller et al. 19996,2000). Collectively, these studies 
have included detailed evaluations of long-term effectiveness 
and health effects on individuals of this treatment (Miller et 
al. 19996, 2001), as well as quantitative data from limited 
field applications (Turner et al. 1997, Warren et al. 1997, 
McShea et al. 1997). A 9-year study of PZP-injected deer at 
Pennsylvania State University showed vaccinated deer 
returned to fertility within 4 to 7 years after vaccinations 
ceased (Miller et al. 2000). A long-term blood chemistry 
survey study on PZP immunized deer found no statistically 
significant health changes in vaccinated deer (Miller et al. 
2001). Over a 4-year period, the health of control and 
treated deer were compared using measurements of body 
weight, serum cholesterol, and blood serum chemistry 
profiles. Although weights of treated deer were slightly less 
than control deer (probably because of early pregnancy of 
controls), no significant differences were found, suggesting 
that the health of the PZP-treated deer was not affected by 
long-term immunocontraceptive treatment (Miller et al. 
2001). Necropsies on 15 deer vaccinated with PZP during a 
2-year study at Seneca h y  Depot, New York, are in 
progress; for deer recently injected with PZP (P. D. Curtis 
and F. Quimby; Cornell University, personal 
communication), some abnormalities were associated with 
the ovaries and uterus, including mild inflammation, 
swelling and localized degeneration of ovarian tissues. 
Nettles (1997) in his health effects review, also cited 
potential ovarian damage in horses, rodents, and rabbits. 
However, the fact that the PZP infertility is reversible 
implies that ovarian damage is reversible as well. 
Other health data on PZP will be required prior to regulatory 
approval and widespread use of the product. The Food and 
Drug Administration requires that standardized Target 
Animal Safety and Drug Tolerance studies (Guideline 33 of 
the FDA Target Animal Safety Guidelines for New Animal 
Drugs) be conducted using the final drug formulation and 
method of administration to determine potential health 
problems for target species. For a Target Animal Safety 
Study, female deer would need to be injected with 3 times 
the standard dose of PZP for 3 consecutive days, followed 
through the fawning season, and then necropsied to 
determine any toxic effect of high multiple doses. For a 
Drug Tolerance Test, female deer would be injected one time 
with 10 times the standard dose of PZP, followed through 
the fawning season, and then necropsied to determine any 
toxic effect of the vely high dose. 
Another expectation of many wildlife managers is that, in 
addition to being safe for treated individuals, contraceptives 
should induce infertility without affecting social behavior. 
As reproduction itself is a "social behavior," this is a difficult 
request and may be impossible or unnecessaq in some 
situations. Behavioral responses to infertility agents are 
variable. Contragestion (interference with early pregnancy) 
vaccines and some steroidal compounds cause disruption of 
implantation, pregnancy, or estrous cycles. Immuno- 
conuaception vaccines GnRH and PZP both result in some 
behavioral changes (Garroa 1995). The PZP vaccine can 
affect social behavior in some species by increasing the 
number of times a mare or doe comes into estrus (estrus was 
occasionally extended into February for white-tailed deer), 
thereby prolonging the breeding season and potentially 
resulting in late summer or autumn b id s .  Care must be 
taken with this product to ensure that the contraceptive 
activity lasts throughout the breeding season to avoid young 
being bom when environmental conditions are unsuitable for 
offspring survival. On the other hand, PZP-induced 
infertility could have minimal behavioral effects on a species 
such as the coyote, which is a monestrous animal. The 
GnRH vaccine causes total reduction of sexual function in 
both males and females, which could be either a desirable or 
undesirable effect in deer, hut in coyotes could potentially 
have the effect of reducing the pair bond between the coyote 
pair. It should be recognized that multiple cycles, failure to 
maintain implantation of the fertilized egg, and females 
sitting on eggs that never hatch are all variations found 
naturally and in most cases may not be of concern. 
The infertility vaccine using human chorionic gonadotropin 
(PhCG) currently being tested in India is a good example of 
a vaccine with little effect on social or sexual behavior. The 
vaccine prevents progesterone production and subsequent 
implantation of the egg in the uterine wall (Talwar and Gaur 
1987). If similar tropic hormones can be identified in 
wildlife, they could provide species specific vaccines with 
few behavioral effects. 
In addition to the physiological and behavioral effects of 
contraceptives on individuals, potentially adverse impacts of 
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their use on wildlife populations also have been an area of 
concern (Nettles 1997). Controlled studies, although 
essential for establishing the physiological and behavioral 
responses to contraceptive agents, also may be of value for 
predicting how populations of treated animals may respond 
and for developing risk assessments for the contraceptives 
used. Even the best human and veterinary drugs are known 
to have some adverse effects in a small percentage of the 
population. Without knowing the incidence of the adverse 
effects in a wildlife population treated with contraceptives, it 
is not possible to assess whether the adverse effect is 
significant or a reasonable trade-off for the benefits derived 
from the contraceptive's use. 
Table 3 may be misleading, because it leaves the 
impression that adverse effects arise from contraceptive 
use without considering that the adverse impacts may be 
offset by beneficial effects. For example, increased energy 
expenditure is cited as a potentially adverse effect in 
populations treated with some contraceptives such as PZP, 
because female deer repeatedly show estrus (Turner et al. 
1996, 1997; McShea et al. 1997; Miller et al. 1999b). 
Although increased activity of females in estrus is well 
documented, energy expenditure for this activity could be 
offset by the reduced expenditure of energy of not being 
pregnant. In terms of survival, it is the net energy 
expenditure of the treated animal that is important, not 
isolated increases or decreases. However, these data 
generally are not available because assessing net energy 
expenditure for individuals presents a difficult challenge 
under controlled conditions, let alone in a free-roaming 
population treated with contraceptives. For example, if 
female deer were treated with the GnRH immuno- 
contraceptive, one would predict their energy expenditure 
would be less because females would not be pursued by 
males and would not invest energy in pregnancy or 
lactation. However, untreated bucks could potentially 
expend more energy in pursuit of females outside of the 
range of the target population. If both males and females 
were treated in the target population with the GnRH 
immunocontraceptive, one would predict little if any 
expenditure of energy for sexual activity or gestation and a 
net decrease in energy expenditures compared to 
nontreated populations. The problem with theoretical 
energy expenditure assessments is that data are often not 
available to define how much positive or negative 
influence each of the known and unknown factors 
contribute to the outcome of the energy expenditure 
equation. 
Contraceptives often are described as affecting the social 
hlerarchy of an animal population (Table 3), but the social 
change may not be truly adverse. For example, although 
the social hierarchy of populations treated with the GnRH 
immunocontraceptives may differ from that of untreated 
populations during the breeding season, it may not differ 
from that during the nonbreeding season. Table 3 also 
includes vasectomy (Kennelly and Converse 1997) and 
hunting as approaches that have been used to limit 
population growth to illustrate that they too have potential 
adverse effects. If males are vasectomized, social 
hierarchy may be maintained, but repeated estrous cycles 
and extended breeding seasons would be predicted for 
females that fail to conceive. Therefore, an increase in 
energy expenditure would be expected for the populations. 
Hunting is the conventional method of population control 
for game species of wildlife, which may have adverse 
effects similar to population control with contraceptives. 
Although adverse effects on individuals are minimal if 
death occurs quickly, animals that are injured, but 
successfully avoid the hunter, may subsequently die from 
the injury or infection. Culling males or females from a 
wildlife population will likely change the social hierarchy 
and the potential genetic pool. The social reshuffling that 
takes place also may result in increased energy 
expenditure. 
Regardless of the method considered for population control, 
there is clearly some difficulty in assessing the true impact 
of each of these potentially adverse effects on animal 
populations and nontarget species. Although some of the 
hypotheses regarding adverse effects may be reasonable, 
most have not been tested experimentally on the species in 
question, and in most instances observations have not been 
made under field conditions to support or refute their 
validity. Moreover, without detailed observations it is not 
possible to know how many potentially interacting factors 
within an animal population will be affected by a 
perturbation. It is likely that the validity of the health and 
population concerns will become apparent only by actual 
testing of contraceptives under semi-free-ranging field 
conditions that will enable data to be gathered for analysis 
and modeling (Bornford and O'Brien 1997). 
The management of wildlife overpopulation through use of 
contraceptives is a goal that has achieved some success, 
particularly in populations limited in number and 
geographically isolated. However, for large free-roaming 
populations the challenge to find an ideal contraceptive that 
will render the target species reversibly infertile without 
some effects on social hierarchy or aspects of individual or 
population biology may not be achievable. Policy makers 
will likely be faced with the fact that some changes that 
occur in response to a contraceptive treatment will be 
adverse, but are less so than the consequences of 
overpopulation of the target species. 
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Risks to Nuntarget Animals 
Ideally, all infertility techniques would be species specific. 
However, this goal is proving difficult to attain. Steroids are 
common to many species; additionally, some of the steroid 
contraceptives accumulate in body tissue and could have 
secondary effects on predators. The current immuno- 
contraceptive vaccines have only limited specificity. The 
GnRH molecule is present in both buds and mammals; 
however, avian and mammalian GnRH are different, 
providing some specificity between classes. Much of 
species specificity in normal mammalian reproduction is 
related to sperm binding to the zona pellucida, yet 
immunizing against porcine zona pellucida (PZP) results in 
infertility across most mammalian species other than cats 
(Jewgenow 2000) and rodents. Rodent zona pellucida is 
unique among mammals; therefore PZP is not effective as a 
contraceptive in rodents (Miller et al. 1997b), and rodent 
zona pellucida contraceptives should not affect other 
nontarget mammals. The bud contraceptives nicarbazin and 
conjugated linoleic acid act on the egg and would not affect 
mammals. 
In the absence of species specificity, one needs to be 
concemed about effects on nontarget species (Guynn 1997). 
When contraceptives are used for population control, the 
potential threat to nontarget species is dependent largely on 
the method used to administer the contraceptive to the tvget 
species (Table 3). Effective delivery of contraceptives to the 
target species may prove to he as difficult as developing an 
effective contraceptive. Delively mechanisms such as 
injection, darting, or implanting require direct contact with 
animals, and are practical only in targeting specific 
populations of limited numbers. If properly implemented, 
there is virmally no chance of nontarget species receiving 
the treatment. In contrast, although the use of oral bait 
delivery systems offers a way to treat larger, free-roaming 
populations at lower cost (Asa 1997), the risk of 
unintentional treatment of nontarget species increases 
significantly. Therefore, if an oral contraceptive delivery 
system is not designed to be limited to the target species, 
then nontarget species could become infertile as well. For 
example, a decade of research toward development of a 
prototype delivery device for oral raccoon rabies vaccination 
(Rupprecht et al. 1987) in the eastem U.S. resulted in a 
fishmeal polymer bait readily consumed by raccoons, yet a 
high percentage of other carnivores and some rodents also 
consumed baits (Rupprecht et al. 1992). When vaccinating 
against disease, consumption of vaccine baits by nontarget 
species presents few problems. However, contraception 
should be limited to the target species and thus the delivery 
system for contraceptive baits should be designed to exclude 
nontargets. To illustrate, if one wanted to orally cause 
infertility in female white-tailed deer, an elevated bait station 
could he designed to exclude nontarget species and allow a 
doe to put its head behveen the bars, but exclude the rack of 
a buck. In some instances, low levels of effects on nontarget 
species may he an acceptable risk, much as a low level of 
nontarget risk is inherent in use of most pesticides. 
The use of infectious biological vectors to deliver 
contraceptive vaccines also could affect nontarget species if 
the infectious organism was not specific to the host species 
(Tyndale-Biscoe 1997). The risks associated with 
dissemination of a biological vector to unintended target 
populations and nontarget species may be too great at this 
time to warrant serious consideration for wildlife 
contraception. However, this approach is under active 
consideration in Australia for control of feral rabbit 
populations (Holland 1999). 
Risks to Humans 
Contraceptives used on huntable species of wildlife pose an 
additional safety consideration-safety to humans who may 
consume them. This risk is minimized by regulatory 
requirements of approval for drugs. Before granting an WAD 
application, the FDA examines the potential for human health 
risk and requires adequate data precluding risk prior to 
allowing human consumption. For compounds that 
accumulate in body tissue and could have secondary effects, 
such as some of the steroid connaceptives, approval would 
not be gmnted for use to cause infertility in food animals such 
as deer and Canada geese without adequate data on chemical 
withdrawal times. Immunocontraception vaccines provide 
few risks for consumptive use of dosed wildlife; an animal 
that has been vaccinated contains antibodies that prevent 
reproduction in addition to millions of other antibodies, all of 
which are harmless to the organism that digests them-like 
any other proteinaceous food consisting of amino acids. The 
FDA is more concerned about the Freund's adjuvant currently 
used with immunocontraceptive vaccines than they are about 
the protein vaccine. An adjuvant is a compound added to the 
vaccine to increase the immune response. For contraceptive 
vaccines to be successful, long lasting titers to the 
conlraceptive antigen must be achieved. To achieve these 
high titers, the most immunogenic contraceptive protein must 
be combined with the best possible adjuvant. Previously, the 
only adjuvants that have provided high and long lasting 
immunocontraceptive responses have been Freund's Complete 
adjuvant (FCA) and a modified FCA produced by 
Calbiochem. Both adjuvants contain mycobacteria; the waxy 
coat of the mycobacteria activates the phagocytic cells to 
ingest the mycobacteria and present the immunocontraceptive 
antigen to the immune system. The presence of mineral oil, 
an indigestible compound, further promotes the antigen 
response by slowing the degradation of the vaccine. These 
qualities make FCA extremely effective. 
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The FDA has objected to the use of FCA for three reasons. 
First, the FDA has had concerns for false-positive TB skin 
tests in deer treated with contraceptive vaccines containing 
FCA (M. tuberculosis). Second, FDA expressed concern 
about the potential carcinogenicity of FCA as it relates to the 
human food safety of edible products derived from treated 
animals. Third, FDA was concerned about the presence of 
granulomatous lesions caused by FCA at the injection site. 
Based on the latter two concerns. FDA has required that 
food animals, such as deer, that are treated with FCA or 
modified FCA be marked with a tag prohibiting human 
consumption. APHISRTSDA has recently developed a new 
adjuvant that appears to be as effective as FCA while having 
few of the negative side effects. APHIS is requesting that 
the FDA allow the new adjuvant to be used in 
immunocontraceptive vaccines without the requirement that 
animals be marked with a tag prohibiting human 
consumption. 
Two of the three infertility agents being researched for birds 
(nicarbazin and CLA) are authorized by the FDA for use in 
broiler chickens and also should have low risk. The third 
compound potentially proposed for birds, DiazaCon, was 
initially designed to be given to humans to lower serum 
cholesterol levels and therefore, should present minimal 
hazard for human consumption at levels that would he 
potentially present in animal tissues. 
REVIEW OF CURRENT 
TECHNOLOGY FOR WILDLIFE 
CONTRACEPTION 
Chemical contraception through the use of synthetic 
steroids, estrogens, and progestins was investigated widely 
during the 1960's and 1970's in many species, such as 
coyotes (Balser 1964; Brusman et al. 1968). pigeons 
(Columba livia, Woulfe 1970), red-winged blackbirds 
(Agelaius phoeniceus, Guarino and Schafer 1973), rats 
(Gartison and Johns 1975). cotumix quail (Coturnix 
coturnir, Schafer et al. 1977), and deer (Matschke 1977~.  
19776, 1980; Roughton 1979). More recently, androgens 
have also been tested for use in male rodents and wolves 
(Asa 1997). These steroid hormones act by interfering with 
ovulation or implantation of the egg in females and by 
impairing spermatogenesis in males. 
Diethylstilbestrol (DES) is a synthetic estrogen that showed 
some success in reducing fertility in female coyotes and 
foxes (Vulpes vulpes) (Balser 1964, Linhart and Enders 
1964, Linhart et al. 1968); it was considered to be of limited 
value, however, because its use required precise timing of 
administration in relation to the breeding cycle. DES had 
variable effects in voles, interrupting early pregnancy or 
causing sterility or delayed sexual maturity of female 
offspring when fed late in pregnancy or during lactation 
(German 1980). DES curtailed all reproduction of prairie 
dogs (Cynomys ludovicianus) when fed during the peak 
breeding period (Garrett and Franklin 1983). Oral doses of 
DES successfully interrupted pregnancy in white-tailed deer 
(Matschke 1977a). but the does rebred and showed poor 
acceptance of subsequent baits, leading to poor efficacy. 
Because it accumulates in body tissue, DES presented 
hazards to predators consuming treated animals and was 
never registered with the EPA. Mestranol is another orally 
active estrogen tested for rodent, rabbit, and bird control. 
The half life of mestranol is less than 6 hours, so retention in 
food chains is not a problem (Sturtevant 1970, 1971), but it 
has caused bait shyness. Mestranol was somewhat 
successful in reducing fertility in birds when force-fed in a 
grit or sprayed on eggs. 
One of the more promising uses of steroids for contraception 
in wildlife has been the delivery of norgestomet (a potent 
progesterone approved by FDA for use in cattle for estrus 
synchronization, Darling 1993) to black-tailed deer 
(Odocoileus hemionus) using a hiobullet (Jacobsen et al. 
1995). The 10 treated does failed to exhibit estrous behavior 
and 2 treated bucks exhibited no sexual behavior for 1 year. 
Additional studies with white-tailed deer (DeNicola et al. 
1997a) confirmed the contraceptive effect of the implant. 
Agents that cause the failure of the fertilized egg to implant 
in the uterine wall, or agents that interfere with the 
maintenance of early pregnancy, are called contragestive 
agents. Given later on in gestation, the technology could be 
considered abortifacient. Progesterone is the main hormone 
involved in maintaining pregnancy. Progesterone 
antagonists, which can be given orally, compete for 
progesterone binding sites but do not induce the biological 
activity needed to maintain pregnancy. These antagonists 
may prove valuable as orally delivered contraceptives or 
contragestive agents. Progesterone antagonists (which are 
difficult for the body to degrade and excrete) can be fed 
monthly as contraceptives or once in early pregnancy to 
intempt pregnancy. They act by causing a sufficient 
disruption in the uterine lining to prevent implantation (Gao 
and Short 1994). The controversial RU486 (mifepristone) 
was evaluated for effectiveness as a contragestive agent in 
coyotes (DeLiberto et al. 1998) without success. 
Lutalysem, produced by Upjohn (prostaglandin PGF2,J, is 
routinely used in feedlot cattle during the first 100 days of 
gestation and will cause abortion within 35 days of injection. 
DeNicola et al. (19976) and Waddell et al. (2001) reduced 
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fertility in white-tailed deer by injecting Lutalyse. 
Depending on the gestational time of administration, the 
technology could be considered either contragestive or 
abortifacient. Lutalyse is available only in an injectable 
form. Several other synthetic progestins (which prevent 
ovulation in female mammals and inhibit testicular activity 
in males) have been identified as having potential as wildlife 
infertility agents. Levonorgestrel (norgestrel) is the active 
component of the Norplanta implant approved for human 
use as a contraceptive implant by FDA (McCauley and 
Geller 1992); it has been used in zoos but was not effective 
in deer (Plotka and Seal 1989, White et al. 1994). 
Norethindron acetate is used in combination with 
ethynylestradiol as an oral contraceptive in humans but has 
not been effective in suppressing estrus in heifers (Kesler 
1997). Megem01 acetate is marketed in Europe as Ovarid@ 
(Kirkpatrick 1989) and in the U.S. as MegaceB and 
Ovabana and is sometimes used as a contraceptive in 
domestic dogs and cats. It showed only weak effects on 
feral cats (McDonald 1980) and no effect on white-tailed 
deer (Matschke 1977b). Medroxyprogesterone acetate 
(proveram) has been used in zoos. Melengestrol acetate 
(MGA) is the steroidal compound most widely tested in 
wildlife and is approved by FDA for use in cattle as a daily 
administration (Zimbelman and Smith 1966) for suppression 
or synchronization of estrus, increased weight gain, and 
improved feed efficiency (Bennett 1993). It inhibited 
reproduction in white-tailed deer when ingested daily 
(Roughton 1979) or implanted (Bell and Peterle 1975, 
Plotka and Seal 1989). MGA implants have been used by 
zoos for about 20 yean, but recent findings of uterine 
pathology in felids have raised concerns about its use 
(Kazensky et al. 1998). 
Some steroid hormone preparations target males rather than 
females (Asa 1997). Bisdiamine is a compound that 
selectively interferes with spermatogenesis but not 
testosterone production. When administered in ground meat 
daily to gray wolves it suppressed spermatogenesis without 
affecting mating behavior. Indenopyridine also blocks sperm 
production; it has been tested only in rodents. Alpha- 
chlorohydrin (Epibloca), a male chemosterilant, was 
approved by the EPA for use as a rat control agent in 1982 
(Bowerman and Brooks 1971, Ericsson 1982, Andrews and 
Belknap 1983), but is no longer marketed. At low doses it 
caused temporary sterilization, with time to recovery of 
fertilization dependent on dose. A single high dose caused 
permanent sterility but showed toxic effects. In addition, rats 
have a promiscuous mating system, so targeting only males 
offered little promise as a population control technique. 
management program based on the use of steroid hormones 
to inhibit reproduction in overabundant animals (Kenneily 
and Converse 1997). Steroids have the advantage that they 
can be fed orally or implanted, and they have been shown to 
be effective for some species. However, none of these 
steroids has proven practical as a wildlife management tool 
for various reasons. Orally, they are effective for only a 
short period and need repetitive applications, making them 
costly and impractical in most field situations. Although 
MGA is effective as an implant for several seasons 
(Matschke 1980), the large implant requires capturing 
animals and performing minor surgery. Some of the 
steroids, such as DES, persist in tissue and in the food 
chain, making them unsatisfactoly from an environmental 
point of view. They can also have deleterious health effects 
on treated animals and potentially on predators that eat 
treated animals (discussed earlier under health effects). 
Natural Plant Compounds 
The livestock industry has been concerned for some time 
about naturally occurring plant compounds that can result in 
lowered reproductive rates in domestic herds (James et al. 
1994). Phytoestrogens naturally occur in over 300 plant 
species (Shemesh and Shore 1994). A constant source of 
estrogen interferes with normal estrous cycles in most 
animals, and phytoestrogens exert many of the same effects 
as estrogen, even though their chemical structure is quite 
different. Another source of reproductive loss in cattle is 
endophyte-infected tall fescue. Ergot peptide alkaloids 
produced by the endophyte are suggested as the primary 
cause of the reduced reproduction (Porter and Thompson 
1991). Vasoconstrictive effects and neurohormonal 
imbalances are thought to be the principal mechanisms 
for the reproductive losses (Browning et al. 1998). 
Bromocriptine (cabergoline) is a derivative of the alkaloid 
ergot family that acts as an enzyme inhibitor of prolactin. 
The lactation-blocking effeco; have been tested on kangaroos 
(Tyndale-Biscoe et al. 1990) by injection into lactating 
females. Bromocriptine is currently being tested in coyotes 
by the NWRC. Plant estrogens and toxins show some 
promise in causing infertility in overabundant animals, but 
much more research on them will be necessary. 
Avian Contraceptives 
Two compounds have been tested in the past for steriiizing 
male red-winged blackbirds: triethylenemelamine ( E M )  
and ThioTEPA (Davis 1961, Vandenbergh and Davis 1962, 
Guaino and Schafer 1973, Potvin et al. 1982). Both 
chemicals caused some reduction in hatching rates, but 
studies did not show an overall population reduction. 
Despite more than four decades of effort, research has yet to 
develop and implement an effective wildlife damage 
Interfering with egg laying or the hatchability of the egg 
appears to he the best approach to reducing reproductive 
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capacity in birds. Egg addling, including shaking, freezing 
puncturing, or oiling the eggs in the nest, effectively reduces 
egg hatchability (Pochop et al. 1998). Egg oiling with corn 
oil is allowed by the EPA under a (FIFRA) 25b exemption 
for natural products, and is being used to reduce 
reproduction in Canada geese (and gulls. However, this 
method is labor intensive and probably useful only in small- 
scale operations. 
Omitrol (DiazaCon) is a cholesterol mimic that has a similar 
chemical structure as cholesterol (Miller and Fagerstone 
2000). DiazaCon has two possible modes of action; it may 
inhibit the formation of cholesterol, or it may inhibit side 
chain cleavage of cholesterol. In both cases, formation of 
pregnenolone (the parent compound of all steroid hormones) 
is reduced, preventing formation of testosterone and 
progesterone. DiazaCon persists in the body because the 
side chain cannot be cleaved, preventing it from being 
excreted like cholesterol, so its reproductive inhibition 
effects can last up to several months. As Omitrol, it was 
registered in the late 1960's with the EPA as an oral pigeon 
reproductive inhibitor, hut the registration was cancelled in 
1993. Although the drug was effective in reducing egg 
laying and egg hatchability (Woulfe 1968), the pigeon is a 
year-around breeder and long-term usage of the compound 
became expensive. Also this product had undesirable health 
effects on the birds (Lofts et al. 196.9, because cholesterol is 
necessary for body functions in addition to production of 
reproductive hormones. Omitrol also showed some success 
in reducing fertility in red-winged blackbirds (Fringer and 
Granett 1970, Lacombe et al. 1987). The compound needs 
to be applied over several days before breeding occurs. In 
recent tests, Yoder (2000) found the compound effective in 
reducing egg laying and egg hatchability up to 4 months in 
cotumix quai1 after feeding it for 10 days. This compound 
(renamed DiazaCon) is authorized for experimental use in 
field situations by APHIS under an INAD application 
through the FDA. It may prove useful in controlling the 
reproduction of seasonal breeding species such as the 
Canada goose when fed just prior to breeding in the spring. 
During the summer, DiazaCon would be cleared from the 
system, allowing animals to be hunted in the fall and to 
breed normally the next season. DiazaCon is not species 
specific, and potentially could be effective in mammalian as 
well as avian species. 
Nicarbazin (NCZ) was developed in the 1950's as a 
compound that controlled coccidiosis (an avian disease) and 
improved weight gain and feed efficiency in broiler 
chickens. If accidentally fed to breeder or layer hens, NCZ 
causes reduction in hatchability and egg laying, apparently 
due to increased vitelline membrane permeability, which 
destroys the conditions necessary for viable development of 
the embryo (Jones et al. 1990). Fertilization is not affected 
by Nicarbazin (Hughes et al. 1991). Nicarbazin has several 
potential advantages as an antifertility agent. Although not 
species specific, it is specific to egg layers, the compound is 
cleared from the body within about 48 hours, and the 
infertility effect is reversible. Nicarbazin is FDA-approved 
for the control of coccidiosis in broiler chickens through 
Koffolk, Inc.; therefore, many required safety and toxicity 
studies have been completed. A disadvantage of the 
compound is that it has to be fed for several days prior to 
egg laying; thus delivery would be a problem in the field. 
Also, formulations or delivery methods would have to he 
developed to limit ingestion by nontarget bird species. 
Nicarbazin is currently being successfully tested on Canada 
geese in penned and field situations by the NWRC under an 
FDA INAD. The ideal dose rate would allow the female to 
lay eggs and sit on them, but prevent hatching, which is a 
relatively common occurrence in nature. 
Conjugated Linoleic Acid (CLA) also is being tested for its 
potential to reduce avian reproduction. CLA is used as a 
feed additive to increase weight gain and feed efficiency in 
broiIer chickens (Chin et al. 1994). Chickens with low grade 
infections produce prostaglandin, which stimulates a fever 
and muscle catabolism, resulting in weight loss of up to 
10%. CLA prevents the synthesis of prostaglandin and 
subsequent weight loss after infections (Miller et al. 1994). 
CLA is sold in health food stores as an antioxidant and 
promoted to reduce the loss of muscle in the elderly that 
results from low grade infections (Pariza 1993). When fed 
to laying chickens, CLA reduces hatchability by causing 
solidification of the yolk at refrigerator temperatures 
(Cooney 1995). In theory, when the clutch is being laid in 
the spring, the bird does not incubate the nest until the 
clutch is complete. As the temperature drops during the 
night the yolk of unincubated eggs from CLA-fed birds 
solidifies, interfering with the hatchability of the eggs. CLA 
is specific to avian species and its infertility effect is 
reversible. It needs to be fed for 10 or more days. A limited 
field trial with Canada geese was ineffective (S. Craven, 
University of Wisconsin, personal communication), but with 
further research the compound could have utility in cold 
climates. 
Immunocontraceptive Vaccines 
Much of the recent infe~tility research has centered around 
immunocontraceptive vaccines. The principle behind the 
vaccines involves using the animal's immune system to 
produce antibodies against gamete proteins, reproductive 
hormones, and other proteins essential for reproduction. 
These antibodies interfere with the normal physiological 
activity of the reproductive agents (Talwar and Gaur 1987). 
This approach is a natural process in the sense that 
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antibodies induced in the target animal interfere with 
reproduction without the need for constant or repetitive 
treatment with synthetic compounds; initial treatments can 
be effective for 1 to 4 years (Turner and Kirkpatrick 1991, 
Miller et al. 19996). 
Reproduction can be blocked at many sites in the reproductive 
process using vaccines. A vaccine can affect both sexes by 
blocking GnRH and preventing the release of essential 
reproductive hormones. A vaccine can selectively d e c t  
females by baning sperm penetration of the zona pellucida. 
Emblyo development can potentially be hindered by preventing 
implantation and development of the fertilized egg via 
antibakes to human chorionic gonadotrophin (hCG) or to 
similar tropic hormones in other species. Sperm proteins also 
can be targeted by vaccines. Most use of immuno- 
contraceptives has been applied to white-tailed deer (Garrott 
1995) and feral horses (Turner and Kirkpatrick 1991); however, 
this technology could also be applied to other wildlife species 
such as rodents, pest species of buds, coyotes, and foxes 
(Miller et al. 1998) if suitable delivery systems are developed. 
Zona Pellucida 
Reproduction in female mammals can be prevented by 
antibodies that bar sperm penetration of the zona pellucida 
of an ovulated egg by binding either to the zona pellucida or 
to the sperm. Zona pellucida is an acellular glycoprotein 
layer located between the oocyte and the granulosa cells on 
the outer surface of the egg. Antibodies to this glycoprotein 
layer result in infertility either by blocking the sperm from 
binding to and penetrating the zona pellucida layer or by 
interference with oocyte maturation, leading to the death of 
the developing oocyte (Dunbar and Schwoebel 1988). The 
zona pellucida vaccine in use today comes from the pig 
ovary-Porcine Zona Pellucida (PZP). PZP vaccine has 
been used to produce immunocontraception in numerous 
species, including dogs (Mahi-Brown et al. 1985), baboons 
(Dunbar 1989), coyotes (Miller 1995, Deliberto et al. 1998), 
and burros (Equus asinus, Turner et al. 1996). Most 
research bas been on wild horses (Kirkpatrick et al. 1990, 
Garrott et al. 1992) and white-tailed deer (Turneret al. 1992, 
1996, Miller et al. 1999b). 
The contraceptive effect is titer dependent. Injecting with an 
initial and a booster dose of PZP vaccine is effective in 
causing infertility in deer and horses for several years. 
Miller et al. (1999b) aclueved 89% reduction in fawning 
during 2 years of active immunization and 76% reduction in 
fawning over the 7-year study. A 2-year study by Cornell 
University and the NWRC, conducted at the Seneca Anny 
Depot, demonstrated that the same contraceptive effect can 
be achieved in deer by using darts to administer an initial 
and a booster vaccination. 
As an injected protein broken down in the body, PZP does 
not enter the food chain. Also, its effects are reversible after 
short-term use. Disadvantages are that PZP is not species 
specific and is effective in reducing fertility in most 
mammals tested other than rodents (Miller et al. 19976) and 
cats (Jewgenow et al. 2000), which have very different zona 
pellucida antigenic determinants. Because of the similarity 
of effects for most mammal species, care must be taken in 
the delivery system to provide the vaccine only to the target 
animal. The PZP vaccine induces multiestrus in female deer 
and feral horses, which could result in late season births if 
antibody titers drop below a critical threshold. 
Gonadotropin Releasine Hormone (GnRH1 
Another active area of research (Jones 1983, Griffin 1992) is 
use of GnRH immunocontraceptive vaccine to inhibit the 
reproductive activity of both sexes by causing development 
of antibodies blocking GnRH. Antibodies to GnRH reduce 
the circulating level of biologically active GnRH, thereby 
reducing the subsequent release of gonadotropic hormones, 
leading to atrophy of the gonads and concomitant infertility 
of both sexes (Miller et al. 19976). GnRH as a contraceptive 
vaccine has been researched in domestic farm animals for 
over 10 years, but little research has been done on wildlife 
species. Two forms of GnRH (avian and mammalian) 
have been identified (Sad et al. 1993, Meloen et al. 1994). 
GnRH contraceptive vaccines have been evaluated as 
immunocastration agents in pets (Ladd et al. 1994), cattle 
(Robertson 1982, Adams and Adams 1992). horses (Rabb et 
al. 1990), sheep (Schanbacher 1982), and swine (Meloen et 
al.1994). Miller et al. (1997b) immunized Norway rats with 
GnRH and created 100% infertility in both males and 
females. Miller et al. (2000) recently completed a long-term 
study on the effect of GnRH on white-tailed deer that 
demonstrated an 86% reduction in fawning during active 
immunization and a 74% reduction over 5 years. 
GnRH is not species specific, although the presence of 
different avian and mammalian forms of GnRH would 
reduce the number of susceptible nontarget species. 
Mammalian GnRH is effective in reducing fertility in most 
mammals, including rodents. Its contraceptive effects last 1 
to 2 years without boosting and are reversible. GnRH 
affects social behavior by reducing the sexual activity of 
both sexes. It is presently available only in injectable form 
and, like PZP, requires an initial and a booster injection. 
GnRH treatment may be a useful technique where sexual 
activity itself creates human-wildlife conflicts. In deer, 
where fall sexual activity has been associated with increased 
deer-vehicle collisions, GnRH could potentially reduce 
damage by reducing deer movement related to sexual 
activity. In cases where tame male deer have been fed in a 
park setting, GnRH also could reduce danger of aggressive 
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behavior to humans during the fall ~ t .  However, for some 
species reducing sexual behavior may not be advantageous; 
for example GnRH could potentially reduce pair bonds in 
animals like coyotes (DeLiberto et al. 1998). 
S o e m  Antibodies 
S p e m  vaccines are promising because they can potentially 
disrupt fertility in females as well as in males. Sperm head 
glycoproteins that bind to zona pellucida have been 
identified. If these glycoproteins are used as vaccines, 
antibodies are produced in the female and are available to 
bind to sperm present in the oviduct, preventing conception 
by blocking the sperm from binding to the zona pellucida 
surrounding the egg. Sperm protein immunocontraception is 
being investigated for contraception in the red fox and the 
rabbit in Australia (Tyndale-Biscoe 1991, Morel1 1993, 
Bradley 1997). 
Chorionic Gonadotrooin 
Human chorionic gonadotropin, which is produced by the 
implanting embryo in humans, induces the corpus luteum on 
the ovary to continue production of the hormone 
progesterone required for the maintenance of pregnancy. 
Antibodies to hCG reduce the activity of this hormone, 
interfering with the maintenance of the uterine lining, and 
thereby preclude successful implantation of the fertilized 
egg, which sloughs off and is reabsorbed (Stevens 1992). 
An hCG vaccine would induce infertility with little effect on 
the social and sexual behavior of the species involved. 
Contraception clinical trials are underway at the National 
Institute of New Delhi testing effectiveness of a hCG 
vaccine on fertile women (Talwar et al. 1994). Primates and 
horses are the only two mammals known to use CG 
(chorionic gonadotropin) as a key tropic reproductive 
hormone. It is possible that feral horse numbers, which have 
become a problem on Bureau of Land Management (BLM) 
lands, could be reduced by fertility reduction through 
inducing antibodies to CG. Many species use other tropic 
hormones to maintain the implanted embryo, and all are 
probably involved with controlling the common gestational 
hormone progesterone. Because of apparent differences 
among species in tropic hormones, vaccines against these 
hormones may provide the best possibility of species 
specificity if these hormones can be identified. 
Contraception Without Steroids or Immunological Methods 
Gonadotro~in Releasing Hormone (GnRH) Azonist 
Gonadotropin releasing hormone is an endogenous 
decapeptide neurohormone with an obligatory role in 
reproduction. This hormone is synthesized and secreted in 
the hypothalamus of the brain and selectively stimulates the 
pituitaty gonadotroph cells to release 2 important 
reproductive hormones, follicle stimulating hormone (FSH) 
and luteinizing hormone (LH). These latter 2 hormones 
control proper functioning of the ovaries in the female and 
the testes in the male. The structure of GnRH has been 
determined (Matsuo et al. 1971) and numerous superactive 
analogs of the hormone (agonists) have been synthesized 
(Vale et al. 1976). The GnRH agonist analogs most 
commonly used to clinically suppress the pituitary-gonadal 
axis include leuprolide, buserelin, nafarelin, and histrelin. 
These analogues are 15 to 200 times more active than 
naturally occurring GnRH (Conn and Crowley 1991). 
Pituitary gonadotrophs can be made unresponsive to GnRH 
by administering an agonist of GnRH in a continuous 
manner. Prolonged, continuous infusion of a GnRH agonist, 
especially at high concentrations, results in desensitization 
and suppression of gonadotropin secretion and loss of 
gonadal function (Clayton et al. 1979). However, when 
administration of the GnRH agonist is discontinued, fertility 
returns. The practicality of this approach is therefore 
dependent on the development of a long-acting, slow-release 
formulation that can be delivered remotely. Recently, a 
practical mode of delivery using subcutaneous or 
intermuscular implants has overcome the need for constant 
mechanical infusion of the agonist. Slow release 
formulations of GnRH agonist are now commercially 
available and have been shown to be effective in suppressing 
gonadal function for up to 6 months in some species. 
Continuous treatment with a GnRH agonist will inhibit 
ovulation in females of several species (Nett et al. 1981, 
Adams and Adams 1986, Khalid et al. 1989), including dogs 
(Vickery et al. 1989), catrle (Herschler and Vickery 1981). 
sheep (McNeilly and Fraser 1987), horses (Montovan et al. 
1990), and stumptailed monkeys (Fraser 1983). Similar 
studies for wild ungulates are more limited. Continuous, 
subcutaneous infusion of HistrelinTM via osmotic minipump 
inhibited LH secretion and ovulation in female white-tailed 
deer for 14 days (Becker and Katz 1995). Leuprolide 
administered as a subdermal mauix implant was effective in 
suppressing LH secretion and pregnancy for one breeding 
season in captive mule deer (Odocoileus hemionus) and elk 
(Cervus elaphus, Baker et al. 2000). No negative behavioral 
or physiological side effects were reported in these 
investigations. 
Gonadotrooin Releasine Hormone (GnRH)-Toxin Conjugate 
For most wild ungulate applications, a single dose, long- 
acting contraceptive offers the most promising technology 
for population management (Hohbs et al. 2000). A 
promising new nonsteroidal, nonimmunological approach to 
permanent contraception involves linking synthetic analogs 
of GnRH to cytotoxins. By coupling a superactive analog of 
GnRH to a cytotoxin, it is possible to specifically target that 
toxin to LH- and FSH-secreting cells in the anterior pituitary 
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gland. GnRH is responsible for secretion of LH and FSH in 
both males and females, and its structure is highly conserved 
across species. Therefore, a single GnRH-toxin conjugate 
has the potential to induce sterility in both sexes and 
numerous vertebrate species. 
There are many natural cytotoxins available for conjugating 
to the GnRH molecule. Many toxins are composed of two 
subunits, a toxin subunit and a binding subunit. The binding 
subunit of most toxins interacts with a protein on the surface 
of cells. Once binding has occurred, the toxin is internalized 
via endocytosis, and the binding unit dissociates from the 
toxic subunit in lysosomes. The toxic subunit then crosses 
the lysosomal membrane and enters the cytoplasm of the 
cell. Within 24 hours a single toxin molecule can inactivate 
most (if not all) of the two million EF-2 molecules in a 
typical animal cell; when the cell is unable to make protein, 
it dies. To target the toxin to a specific cell type (rather than 
all cells) within the body, the binding subunit of the toxin 
can be removed and replaced by a molecule that will bind to 
only one cell type, in this case an analog of GnRH. This 
will target the toxin to gonadotropin-secreting cells in the 
anterior pituitary. This approach has several potential 
advantages over other methods of contraception: (1) a single 
treatment may permanently sterilize an animal; (2) the 
treatment should be effective in both males and females and 
in all vertebrate species; (3) the GnRH-toxin conjugate is 
metabolized from the body within 24 hours of treatment; 
(4) the proteinaceous name of the GnRH-toxin conjugate 
eliminates the possibility of passage through the food chain; 
(5) the small volume required for effective contraception 
would facilitate microencapsulation and administration by 
syringe dart or biobullets. 
At present, clinical trials are being conducted with dogs, 
cats, sheep, mule deer, and elk to evaluate the effectiveness 
of ribosome-inhibiting proteins extracted from plants as 
toxins for permanently deactivating pituitary gonadotroph 
cells. To date, no long-term investigations have been 
conducted to evaluate the effective duration of GnRH-toxin 
conjugate in suppressing gonadotroph function. Preliminary 
results in female mule deer indicate that GnRH-toxin 
conjugate will suppress LH secretion for up to 6 months 
(Baker et al. 1999). Safety studies have not been reported. 
Since there are GnRH receptors in other sites in the body, 
toxicity could be a potential problem with this technique. 
SUMMARY 
As we study the habits of most overabundant species, we 
generally find that they are adaptable to multiple and 
changing environments. That is why their populations 
increase in spite of a rapidly changing landscape. Wildlife 
contraceptive programs have been less successful than hoped 
in the past due to a lack of long-acting fertility control 
agents, as well as failure to understand mating strategies and 
related behavior patterns of species targeted for reproductive 
control. With an increasing research focus on contraceptive 
development, and knowledge of animal reproductive systems 
and behaviors, fertility control as a technology is advancing 
rapidly. Major hurdles still include development of cost- 
effective delivery systems for effective products, 
commercialization of vaccines or baits, and public 
acceptance of fertility control as a wildlife management 
practice. 
Warren (1995). in a discussion of factors relevant to the 
practical and logistical implementation of contraceptives for 
controlling wildlife, correctly pointed out that contraceptive 
development requires a team approach involving laboratory 
scientists (e.g., immunologists, molecular biologists, 
reproductive physiologists) to develop the contraceptive 
techniques and wildlife biologists to develop delivery 
systems and methods to measure field efficacy and safety. 
Although laboratory scientists have made remarkable 
progress over the last 10 years in techniques development, 
the partnership with wildlife biologists and wildlife 
management agencies is just beginning. 
There are currently no contraceptive products available for 
commercial use, and there are many barriers to overcome 
before commercial use will occur. Several products have 
been given an INAD number by the FDA allowing use under 
research protocols in laboratory studies, pen studies, and in 
limited field situations with small numbers of animals. But 
before contraceptives can be used by wildlife managers other 
than researchers, FDA will undoubtedly require that 
manufacturers of products obtain a NADA, which will 
require additional health and safety trials, efficacy trials, and 
final manufacturing methods. Because contraceptive 
products for wildlife use will be a minor market, and the 
cost of obtaining authorization for their use by the FDA will 
be high, drug manufacturers will be reluctant to develop 
products on their own. Researchers, wildlife managers, and 
management agencies will need to be involved in 
development of products along with the drug manufacturers. 
Development could occur by (1) focusing on products 
already licensed by FDA for other purposes, which will cost 
less to develop as an approved product for infertility use, 
(2) building partnerships with drug manufacturers to develop 
lucrative alternative uses such as animal production or pet 
neutering, or (3) providing direct funding and support for 
development. Product development is a nontraditional role 
for wildlife management agencies, but one that will be 
required if contraceptive products are to be used in anything 
other than a research context. 
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For any wildlife contraceptive product, there will be a 
number of health and behavior-related issues concerning use 
on target and nontarget species and effects on humans. First, 
infertility agents should have few adverse health effects on 
target animals. Second, they should not affect nontarget 
species adversely. Because technology is not currently 
available to make infertility agents species specific, delivery 
systems should be developed to limit effects on nontarget 
species. Third, treated food animals must be safe for human 
consumption. Products used on huntable species of wildlife 
could pose potential risks to humans who consume them. 
These risks are minimized by regulatory requirements of 
approval for drugs through the FDA. Fourth, infertility 
agents should result in little negative social effect on the 
target species, recognizing that because reproduction itself is 
a "social behavior," this is a difficult request and may be 
impossible or unnecessary in some situations. Fifth, for 
certain cases the infertility effect should be reversible. Most 
of the infertility agents discussed in this paper are reversible, 
but there is a large variation in the length of time that they 
are effective. Because much of the health and population 
information currently available is based on limited studies 
and conjecture, further controlled studies are needed to 
evaluate the physiological effects of specific contraceptives 
on individuals and populations of a target species. Results 
from these studies should provide reliable information for 
risk assessment so agencies involved with wildlife 
management are able to make informed decisions for policy 
implementation. 
An additional hurdle to overcome before use of 
contraceptives is an accepted wildlife management practice 
is the attitude of wildlife management agencies. Many 
wildlife agencies and biologists have been reluctant to 
acknowledge the potential applicability of fertility control 
for managing wildlife populations (Warren 1995). In part, 
this is because the techniques available have been publicized 
as a replacement for sport hunting. In reality, it is doubtful 
if the cost of delivery for contraceptive techniques would 
allow their use on free-ranging game populations. The 
current techniques often have been uneconomical or 
infeasible for practical implementation even in small 
localized populations of game species such as deer. And the 
species for which contraceptives have been primarily tested 
(long-lived species such as deer and horses) are those that 
are least suited for population reduction through use of 
fertility control. From the perspective of population 
dynamics, infertility agents are best suited for management 
of short-lived, highly fecund wildlife populations such as 
rodents and small birds. 
This finding conflicts with the growing public desire for 
nonlethal methods sucb as reproductive control to solve 
human wildlife conflicts. Despite the h g h  cost and 
sometimes questionable feasibility of present contraceptive 
programs, more and more communities are opting to fund 
reproductive control of wildlife populations such as deer. 
Wildlife management agencies are increasingly being forced 
to consider the views of the public, as the public is 
demanding a voice in wildlife management, even to the 
point of filing lawsuits and passing local and state 
referendums. The public views contraceptives as a positive 
alternative to other management tools, and managers are 
increasingly being forced to become active partners with the 
public in developing practical applications for this 
technology. Public forums discussing the advantages and 
disadvantages of various management techniques will be 
more important in the future. The challenge for wildlife 
managers for many species will be to integrate potentially 
valuable contraceptive technologies with more conventional 
methods of wildlife population management. Furthermore, 
if infertility agents are developed and used on long-lived 
species sucb as deer and geese, biologists need to be honest 
with the public about the inefficiencies of this approach and 
the length of time required for such strategies to reduce 
populations relative to lethal control. 
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Table 1. List of Acronyms 
Acronym Compound Term Acronym Compound Term 
AAWV American Association of Wildlife FFDCA Federal Food, Drug and Cosmetic Act 
Veterinarians FIFRA Federal Insecticide, Fungicide, and 
APHISIUSDA Animal and Plant Health Inspection Service1 Rodenticide Act 
U.S Department of Agriculture FSH follicle stimulating hormone 
ASR adult survival rate FWS Fish and Wildlife Service 
BCG Bacillus calmerte guerin GnRH gonadotropin-releasing hormone 
BLM Bureau of Land Management hCG human chorionic gonadotrophin 
CFR Code of Federal Regulations INAD Investigational New Animal Drug 
CG chorionic gonadotrophin IPM integrated pest management 
CLA conjugated linoleic acid LH luteinizing hormone 
CSIRO Commonwealth Scientific and Industrial MGA melengestrol acetate 
Research Organization NADA New Animal Drug Application 
DES diethylstilbestrol NCZ nicarbazin 
EPA Environmental Protection Agency NEPA National Environmental Policy Act 
FCA Freund's complete adjuvant NWRC National Wildlife Research Center 
CVMFDA Center for Veterinary MedicineEood and pZp porcine zona pellucida 
Drug Administration 
TEM triethylenemelamine 
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Table 2. Estimated relative efficiency of reproductive and lethal control based on numbers remaining after 3 years from an 
initially stable population of 1,000 individuals in which reproductive or survival rate is reduced annually by 50% (using 
population models presented in Dolbeer 1998). 
Number remaining after 3 years Relative efficiencya of lethal 
Lethal to reproductive conuol 
Reproductive control (LC) ( R C ~ C )  after 3 years 
Species control (RC) - >Age Ob - >Age lC  - >Age Ob 2 Age 1C 
Fruit bat (Ptempus giganteus) 73 1 125 191 5.8 3.8 
Laughing gull (Larus ntricilla) 720 125 180 5.8 4.0 
Double crested cormorant 673 125 183 5.4 3.7 
White-tailed deer 639 125 212 5.1 3.0 
Beaver (Castor camdensis) 624 125 199 5.0 3.1 
Canada goose 607 125 193 4.9 3.1 
Coyote 486 125 264 3.9 1.8 
Common grackle (Quiscalus quiscala) 460 125 349 3.7 1.7 
Brown-headed cowbird 338 125 462 2.7 1.3 
Red-billed quelea 368 125 421 2.9 0.7 
Black rat 97* (406)e 307= 675d 0.3C 0.6d 
a Efficiency ratios presented are specific to population status after 3 years and will increase during additional years of treatment. 
b Survival reduced 50% for age classes 2 0. 
C Survival reduced 50% for age classes 2 1 
* Survival and reproduction of adults (23 months old) reduced 3 timeslyear. 
Survival and reproduction of adults @3 months old) reduced 1 timelyear 
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